{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:09:13Z","timestamp":1777356553660,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7450,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1023\/a:1008377819875","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"943-947","source":"Crossref","is-referenced-by-count":71,"title":["Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma"],"prefix":"10.1016","volume":"10","author":[{"given":"M.L.","family":"Dunsford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008377819875_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/oxfordjournals.annonc.a059105","article-title":"The treatment of advanced bladder cancer","volume":"6","author":"Sternberg","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008377819875_bb0065","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1200\/JCO.1997.15.7.2564","article-title":"Longterm follow up of a phase III intergroup study of cisplatin alone or in combinaton with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: A Co-Operative Group Study","volume":"15","author":"Scott","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008377819875_bb0070","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.1997.15.11.3394","article-title":"Phase II study of single-agent gemcitabine in previous untreated patients with metastatic urothelial cancer","volume":"15","author":"Stadler","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008377819875_bb0075","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00001813-199707000-00004","article-title":"Activity of gemcitabine in the treatment of patients with non-small-cell lung cancer: A multicentre phase II study","volume":"8","author":"Yokoyama","year":"1997","journal-title":"Anti Cancer Drugs"},{"key":"10.1023\/A:1008377819875_bb0080","first-page":"27","article-title":"Phase II trial of gemcitabine and weekly cisplatin for advanced non-small-cell lung cancer","volume":"24","author":"Shepherd F","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008377819875_bb0085","article-title":"Phase II study with gemcitabine in pre-treated patients with Hodgkins (HD) and non\u2013Hodgkins lymphoma (NHL): Results of a multicentre study","volume":"16","author":"Santoro","year":"1997","journal-title":"PROC ASCO"},{"key":"10.1023\/A:1008377819875_bb0090","first-page":"S7","article-title":"Phase II studies of gemcitabine for non-small-cell lung cancer in Japan","volume":"24","author":"Fukuoka","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008377819875_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/bjc.1996.18","article-title":"Phase II study of gemcitabine in patients with advanced pancreatic cancer","volume":"73","author":"Carmichael","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008377819875_bb0100","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1200\/JCO.1995.13.11.2731","article-title":"Advanced breast cancer: A phase II trial with gemcitabine","volume":"13","author":"Carmichael","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008377819875_bb0105","article-title":"A phase II trial of gemcitabine and paclitaxel administered on an every other week schedule","volume":"7","author":"Rothenberg","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008377819875_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(97)85277-X","article-title":"Preliminary results from an early phase II combination of gemcitabine and Taxol in metastatic breast cancer","volume":"33","author":"Sanchez-Rovira","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008377819875_bb0115","first-page":"1819","article-title":"Front-line treatment of advanced non-small-cell lung cancer (NSCLC) with docetaxel (D) and gemcitabine (G): A multicentre phase II trial","volume":"17","author":"Georgoulias","year":"1988","journal-title":"Proc ASCO"},{"key":"10.1023\/A:1008377819875_bb0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1097-0142(19970715)80:2<286::AID-CNCR17>3.0.CO;2-Q","article-title":"Fatal pulmonary toxicity resulting from treatment with gemcitabine","volume":"80","author":"Paviakis","year":"1997","journal-title":"Cancer"},{"key":"10.1023\/A:1008377819875_bb0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1008226416896","article-title":"Docetaxel and interstitial pulmonary injury","volume":"8","author":"Merad","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008377819875_bb0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-124-2-199601150-00030","article-title":"Transient pulmonary infiltrates: A hypersensitivity reaction to paclitaxel","volume":"124","author":"Ramanathan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1023\/A:1008377819875_bb0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1378\/chest.110.1.289","article-title":"Pulmonary infiltrates following administration of paclitaxel","volume":"110","author":"Ramesh","year":"1996","journal-title":"Chest"},{"key":"10.1023\/A:1008377819875_bb0140","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1177\/106002809703101205","article-title":"Paclitaxel-induced acute bilateral pneumonitis","volume":"31","author":"Khan","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1023\/A:1008377819875_bb0145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7","article-title":"Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel","volume":"76","author":"Schweitzer","year":"1995","journal-title":"Cancer"},{"key":"10.1023\/A:1008377819875_bb0150","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1200\/JCO.1996.14.4.1071","article-title":"Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer","volume":"14","author":"Reckzeh","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008377819875_bb0155","first-page":"2476","article-title":"Pulmonary changes in patients with lymphoma who receive paclitaxel","volume":"15","author":"Ayoub","year":"1997","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1023\/A:1008377819875_bb0160","first-page":"123","article-title":"Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation","volume":"24","author":"Bonomi","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008377819875_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2214\/ajr.149.1.23","article-title":"Pulmonary complications of cytosine-arabinoside therapy: Radiographic findings","volume":"149","author":"Richenel","year":"1987","journal-title":"AJR"},{"key":"10.1023\/A:1008377819875_bb0170","first-page":"3","article-title":"Gemcitabine: Metabolism, mechanisms of action and self-potentiation","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008377819875_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001813-199512006-00005","article-title":"Safety profile of gemcitabine","volume":"6","author":"Tonato","year":"1995","journal-title":"Anti-Cancer Drugs"},{"key":"10.1023\/A:1008377819875_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03003180","article-title":"Non-cardiogenic pulmonary complicating intermediate and high-dose ARA C treatment for relapsed acute leukaemia","volume":"5","author":"Jehn","year":"1988","journal-title":"Med Oncol Tumour Pharmacother"},{"key":"10.1023\/A:1008377819875_bb0185","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/1097-0142(19941001)74:7<1953::AID-CNCR2820740721>3.0.CO;2-E","article-title":"Pulmonary insufficiency complicating therapy with high-dose cytosine arabinoside in five pediatric patients with relapsed acute myelogenous leukaemia","volume":"74","author":"Shearer","year":"1994","journal-title":"Cancer"},{"key":"10.1023\/A:1008377819875_bb0190","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9343(81)90759-2","article-title":"Ara-C lung: Non-cardiogenic pulmonary oedema complicating cytosine arabinoside therapy of leukaemia","volume":"70","author":"Haupt","year":"1981","journal-title":"Am J Med"},{"key":"10.1023\/A:1008377819875_bb0195","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/1097-0142(19851101)56:9<2181::AID-CNCR2820560907>3.0.CO;2-B","article-title":"Subacute pulmonary failure complicating therapy with high-dose ara-C in acute leukaemia","volume":"56","author":"Anderson","year":"1985","journal-title":"Cancer"},{"issue":"5","key":"10.1023\/A:1008377819875_bb0200","first-page":"5197","article-title":"Dyspnoea with gemcitabine is commonly seen, often diseaese related, transient and rarely severe","volume":"31A","author":"Nelson","year":"1995","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1023\/A:1008377819875_bb0205","first-page":"36","article-title":"A phase II trial of gemcitabine and ifosfamide in non-small-cell lung cancer","volume":"24","author":"Gatzemeier","year":"1997","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1023\/A:1008377819875_bb0210","first-page":"68","article-title":"Radiosensitization of human tumour cells by gemcitabine in vitro","volume":"22","author":"Schewach","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008377819875_bb0215","first-page":"1923: 499a","article-title":"Gemzar (gemcitabine) with thoracic radiotherapy\u2014a phase II pilot study in cheonaive patients with advanced non-small-cell lung cancer (NSCLC)","volume":"17","author":"Scalliet","year":"1998","journal-title":"Proc ASCO"},{"issue":"14","key":"10.1023\/A:1008377819875_bb0220","first-page":"22","article-title":"Docetaxel (Taxotere) and gemcitabine in the treatment on non-small-cell lung cancer. Preliminary results","volume":"4","author":"Georgoulia","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008377819875_bb0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.1998.16.1.159","article-title":"Phase I study of docetaxel with concomitant thoracic radiation therapy","volume":"16","author":"Mauer","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419573094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419573094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/10\/8\/943\/19477882\/10-8-943.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:45:01Z","timestamp":1682009101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419573094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["S0923753419573094"],"URL":"https:\/\/doi.org\/10.1023\/a:1008377819875","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}